ESMO - European Society for Medical Oncology

🌐 Are tumour-agnostic therapies ready for prime time — and how can we accelerate their adoption? At #ESMO25, two dedicated symposia will explore the science, clinical perspectives, and regulatory challenges shaping this innovative approach: 📌 Tumour-agnostic anticancer therapies: Ready for prime time? ✔ Approved targeted agnostic therapies ✔ Immunotherapy and ADCs in a tumour-agnostic setting ✔ Biomarkers for drug development ✔ Emerging targets and precision therapeutics 📌 Accelerating tumour-agnostic therapies ✔ Clinician, statistician, and molecular biology perspectives ✔ Regulatory considerations for implementation 📅 18 & 20 October | Berlin 🔗https://ow.ly/LqPa50XbbBb

AI and digital innovation are redefining cancer care, from clinical trials to patient monitoring. Are you ready to explore what’s next? Join us at #ESMO25 for plenty forward-thinking sessions: 📌 AI-based image biomarkers in oncology, radiology and pathology - Gain insights into AI in cancer image analysis, its current use in pathology and radiology, and its convergence for precision oncology. 📌 Clinical trials in the age of AI - Learn about AI-based procedures to augment trials, precision medicine beyond genomic tests, digital infrastructure, and AI-driven drug discovery 📌 Digital tools for off-site care - Evidence supporting remote monitoring, implementation of digital tools, and next steps in their development. 📌 ChatGPT and cancer care - Understand large language models in oncology, lessons from implementation, their role in drug development, and agentic AI. ELCAP (ESMO guidance on the use of Large Language Models in Clinical Practice) unveiled! 📅 17–19 October

Many journeys. #ONEoncologycommunity. As part of our commitment to building a #GlobalCommunity, we have created dedicated selfie locations across the #ESMO25 venue. These spaces amplify the voices of #OncologyProfessionals from across the globe. Do you want to be a part of it? 🤳Whether you are attending #ESMO25 alone or with colleagues, take a photo at one of our 50th anniversary banners. 🗣️ Use #myESMOStory and share how being an ESMO member has impacted your #ProfessionalJourney. 👥Tag ESMO and those who have accompanied you along your #ProfessionalPath. 🔗 https://ow.ly/TE3X50X9Nmr Teresa Amaral MD, PhD; Evandro de Azambuja; Angela Lamarca; Jonathan Lim

⏳ Just a few hours before #ESMO25 takes off...What can we expect?   The Scientific Co-Chairs share their insights on this year’s Congress.    🎥 Watch the video and discover what’s to come  Myriam Chalabi Toni Choueiri

#ESMO25: 📲 Whether you're a first-time or a seasoned congress attendee, the app helps you stay on top of what matters most to you. Explore the full programme, bookmark your favourite sessions, and build your personalised schedule — all in one place. 👇 Below is a selection of session descriptions to support the planning and enhance the overall Congress experience. 📌Educational Session: expert talks and a Chair-led discussion, for a balanced up-to-date overview of key topics with interactive Q&A. 📌Multidisciplinary Session: case-based session, interactive discussion and audience engagement on complex approaches. 📌Special Symposium: 4–5 expert talks, with opening and closing remarks and final discussion. 📌Proffered Paper Session: Oral presentations with original significant findings followed by expert discussion and perspectives #MyFirstESMO

🔔 Heads up: the Late Breaking Abstracts of #ESMO25 will be available online at 00:05 on the day of their presentation. Stay tuned for the latest research breakthroughs and clinical changes in #oncology.

New this year, the #ESMO25 Opening Session will include the presentation of the inaugural ESMO Oncologist of the Year Award to Glenda Ramos Martinez. She will be recognised for her pioneering role in advancing oncology in Ecuador, her commitment to expanding continuing medical education, and her advocacy for improving access to #CancerMedicines.

What lies beyond immune checkpoint blockade in #melanoma treatment? Join the special symposium at #ESMO25: “Emerging new treatment options beyond immune checkpoint blockade (ICB)” 📅 17 October | 14:00–15:30 | Bremen Auditorium – Hall 6.2 Discover why moving beyond ICB is essential, explore the promise of #AdoptiveCellTherapy, learn strategies for treating unresectable stage IV melanoma, and get insights into bispecific T-cell engagers. 🔗 https://ow.ly/2Oan50XaEvs

The 2025 ESMO Lifetime Achievement Award recipient, Rolf Stahel will deliver his Award lecture during the #ESMO25 Opening Session reflecting on a career marked by visionary leadership and enduring contributions to oncology. His work has profoundly shaped #ClinicalResearch, education, and international collaboration in the field.  📅Do not miss the Opening Session as it features Award lectures that highlight excellence in oncology and set the tone for the scientific programme to follow. 👉https://ow.ly/MGOk50XawBJ

👩⚕️ Young Oncologists at #ESMO25: Learn, connect, grow From mentorship and networking opportunities to interactive case discussions, the Young Oncologists track offers a rich programme designed to empower the next generation of oncology professionals. Highlights include the Vesalius Talk on career twists, a masterclass on genomics, practical brunch sessions on biostatistics, drug repurposing and survivorship, as well as forums on collaboration and educational opportunities through fellowships in Europe. 📅 17–20 October Visit the website for the #YoungOncologist (YO) Track Sessions 🔗https://ow.ly/seq050XaWzU